Literature DB >> 15728632

Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease.

Nandita M deSouza1, Richard O'Neill, G Angus McIndoe, Roberto Dina, W Patrick Soutter.   

Abstract

OBJECTIVE: We sought to describe MDCT and MRI features and tumor marker levels that differentiate borderline ovarian tumors from stage I ovarian tumors.
CONCLUSION: Borderline ovarian tumors are complex masses with imaging features similar to stage I tumors. The thickness of septations and the size of solid components are significantly larger in stage I tumors, and these features may be helpful for predicting likelihood of invasive tumors. However, neither feature allows confident differentiation of borderline tumors from stage I disease.

Entities:  

Mesh:

Year:  2005        PMID: 15728632     DOI: 10.2214/ajr.184.3.01840999

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

2.  Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT.

Authors:  Chulhan Kim; Hyun Hoon Chung; So Won Oh; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-04-04

3.  Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?

Authors:  S M Mansour; S Saraya; Y El-Faissal
Journal:  Br J Radiol       Date:  2015-06-17       Impact factor: 3.039

4.  Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.

Authors:  Shu Hui Zhao; Jin Wei Qiang; Guo Fu Zhang; Feng Hua Ma; Song Qi Cai; Hai Ming Li; Li Wang
Journal:  Eur Radiol       Date:  2014-05-29       Impact factor: 5.315

5.  Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.

Authors:  Rie Mimura; Fumi Kato; Khin Khin Tha; Kohsuke Kudo; Yosuke Konno; Noriko Oyama-Manabe; Tatsuya Kato; Hidemichi Watari; Noriaki Sakuragi; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2016-01-21       Impact factor: 2.374

6.  Proton MR spectroscopy and the detection of malignancy in ovarian masses.

Authors:  Sahar Mahmoud Mansour; Mohammed Mohammed Mohammed Gomma; Peter Nashaat Shafik
Journal:  Br J Radiol       Date:  2019-07-18       Impact factor: 3.039

7.  The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.

Authors:  Ji-Eun Shin; Hyuck Jae Choi; Mi-Hyun Kim; Kyoung-Sik Cho
Journal:  Korean J Radiol       Date:  2011-07-22       Impact factor: 3.500

Review 8.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

Review 9.  MR imaging in ovarian cancer.

Authors:  S A A Sohaib; R H Reznek
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

10.  Difficulties in differentiating the nature of ascites based on ultrasound imaging.

Authors:  Andrzej Smereczyński; Katarzyna Kołaczyk; Elżbieta Bernatowicz
Journal:  J Ultrason       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.